Log In
BCIQ
Print this Print this
 

MVA-BN RSV

  Manage Alerts
Collapse Summary General Information
Company Bavarian Nordic A/S
DescriptionRecombinant MVA-BN based respiratory syncytial virus (RSV) vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsVaccinate against respiratory syncytial virus (RSV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today